Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1989)
All Articles published online
|
May 26, 2011 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Palee S, Chattipakorn S, Phrommintikul A, Chattipakorn N. PPARγ activator, rosiglitazone: Is it beneficial or harmful to the cardiovascular system? World J Cardiol 2011; 3(5): 144-152 [PMID: 21666815 DOI: 10.4330/wjc.v3.i5.144] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v3/i5/144.htm |
| Number | Citing Articles |
| 1 |
Alice Marino, Derek J. Hausenloy, Ioanna Andreadou, Sandrine Horman, Luc Bertrand, Christophe Beauloye. AMP-activated protein kinase: A remarkable contributor to preserve a healthy heart against ROS injury. Free Radical Biology and Medicine 2021; 166: 238 doi: 10.1016/j.freeradbiomed.2021.02.047
|
| 2 |
Marta Tomczyk, Alicja Braczko, Paulina Mierzejewska, Magdalena Podlacha, Oliwia Krol, Patrycja Jablonska, Agata Jedrzejewska, Karolina Pierzynowska, Grzegorz Wegrzyn, Ewa M. Slominska, Ryszard T. Smolenski. Rosiglitazone Ameliorates Cardiac and Skeletal Muscle Dysfunction by Correction of Energetics in Huntington’s Disease. Cells 2022; 11(17): 2662 doi: 10.3390/cells11172662
|
| 3 |
P. N. Mimche, E. Thompson, D. Taramelli, L. Vivas. Curcumin enhances non-opsonic phagocytosis of Plasmodium falciparum through up-regulation of CD36 surface expression on monocytes/macrophages. Journal of Antimicrobial Chemotherapy 2012; 67(8): 1895 doi: 10.1093/jac/dks132
|
| 4 |
Nattayaporn Apaijai, Hiranya Pintana, Siriporn C. Chattipakorn, Nipon Chattipakorn. Cardioprotective Effects of Metformin and Vildagliptin in Adult Rats with Insulin Resistance Induced by a High-Fat Diet. Endocrinology 2012; 153(8): 3878 doi: 10.1210/en.2012-1262
|
| 5 |
Lama Fawaz Pharaon, Naglaa Fathi El-Orabi, Muhammad Kunhi, Nadya Al Yacoub, Salma Mahmoud Awad, Coralie Poizat. Rosiglitazone promotes cardiac hypertrophy and alters chromatin remodeling in isolated cardiomyocytes. Toxicology Letters 2017; 280: 151 doi: 10.1016/j.toxlet.2017.08.011
|
| 6 |
Khodor Abou Daya, Hussein Abu Daya, Mohamad Nasser Eddine, Georges Nahhas, Nuha Nuwayri‐Salti. Effects of rosiglitazone (PPAR γ agonist) on the myocardium in non‐hypertensive diabetic rats 罗格列酮（PPAR γ 激动剂）对非高血压糖尿病大鼠的心肌的影响. Journal of Diabetes 2015; 7(1): 85 doi: 10.1111/1753-0407.12140
|
| 7 |
Dahae Lee, Tuy An Trinh, Myoung-Sook Shin, Ki Sung Kang. Recent Advancements in Microbial Diversity. 2022; : 209 doi: 10.1016/B978-0-12-822368-0.00009-8
|
| 8 |
Maxwell P Treacy, Tara P Hurst. The case for intraocular delivery of PPAR agonists in the treatment of diabetic retinopathy. BMC Ophthalmology 2012; 12(1) doi: 10.1186/1471-2415-12-46
|
| 9 |
Jason C. Hsu, Ching-Lan Cheng, Dennis Ross-Degnan, Anita K. Wagner, Fang Zhang, Yea-Huei Kao Yang, Li-Ling Liu, Hsueh-Yung Tai, Ke-Hsin Chen, Po-Wen Yang, Christine Y. Lu. Effects of safety warnings and risk management plan for Thiazolidinediones in Taiwan. Pharmacoepidemiology and Drug Safety 2015; 24(10): 1026 doi: 10.1002/pds.3834
|
| 10 |
Xian Zhou, Ling Fu, Pengli Wang, Lan Yang, Xiaoshu Zhu, Chun Guang Li. Drug-herb interactions between Scutellaria baicalensis and pharmaceutical drugs: Insights from experimental studies, mechanistic actions to clinical applications. Biomedicine & Pharmacotherapy 2021; 138: 111445 doi: 10.1016/j.biopha.2021.111445
|
| 11 |
Pitchai Balakumar, Sonam Kathuria. Submaximal PPARγ activation and endothelial dysfunction: new perspectives for the management of cardiovascular disorders. British Journal of Pharmacology 2012; 166(7): 1981 doi: 10.1111/j.1476-5381.2012.01938.x
|
| 12 |
Lingling Yu, Shengsong Chen, Qian Liang, Chahua Huang, Weifang Zhang, Longlong Hu, Yun Yu, Liang Liu, Xiaoshu Cheng, Huihui Bao. Rosiglitazone reduces diabetes angiopathy by inhibiting mitochondrial dysfunction dependent on regulating HSP22 expression. iScience 2023; 26(4): 106194 doi: 10.1016/j.isci.2023.106194
|
| 13 |
Jason C. Hsu, Dennis Ross-Degnan, Anita K. Wagner, Fang Zhang, Christine Y. Lu. How Did Multiple FDA Actions Affect the Utilization and Reimbursed Costs of Thiazolidinediones in US Medicaid?. Clinical Therapeutics 2015; 37(7): 1420 doi: 10.1016/j.clinthera.2015.04.006
|
| 14 |
Min Kyu Park, Tae-Eun Kim, JaeWoo Kim, Chin Kim, Seo Hyun Yoon, Joo-Youn Cho, In-Jin Jang, Kyung-Sang Yu, Kyoung Soo Lim. Tolerability and Pharmacokinetics of Lobeglitazone, a Novel Peroxisome Proliferator-Activated Receptor-γ Agonist, After a Single Oral Administration in Healthy Female Subjects. Clinical Drug Investigation 2014; 34(7): 467 doi: 10.1007/s40261-014-0197-y
|
| 15 |
Qitong Zhang, Tong Liu, Chee Y. Ng, Guangping Li. Diabetes Mellitus and Atrial Remodeling: Mechanisms and Potential Upstream Therapies. Cardiovascular Therapeutics 2014; 32(5): 233 doi: 10.1111/1755-5922.12089
|
| 16 |
Hanna Kozłowska, Marta Baranowska-Kuczko, Eberhard Schlicker, Mirosław Kozłowski, Monika Kloza, Barbara Malinowska. Relaxation of human pulmonary arteries by PPARγ agonists. Naunyn-Schmiedeberg's Archives of Pharmacology 2013; 386(5): 445 doi: 10.1007/s00210-013-0846-3
|
| 17 |
Antony Sameh Mansour. Autoregulation: mediators and renin–angiotensin system in diseases and treatments. Future Journal of Pharmaceutical Sciences 2023; 9(1) doi: 10.1186/s43094-023-00482-4
|
| 18 |
Noppamas Pipatpiboon, Jirapas Sripetchwandee, Siriporn C. Chattipakorn, Nipon Chattipakorn. Effects of PPARγ agonist on heart rate variability and cardiac mitochondrial function in obese-insulin resistant rats. International Journal of Cardiology 2015; 201: 121 doi: 10.1016/j.ijcard.2015.07.090
|
| 19 |
Almudena Bermejo, Aida Collado, Isabel Barrachina, Patrice Marqués, Noureddine El Aouad, Xavier Franck, Francisco Garibotto, Catherine Dacquet, Daniel H. Caignard, Fernando D. Suvire, Ricardo D. Enriz, Laura Piqueras, Bruno Figadère, María-Jesús Sanz, Nuria Cabedo, Diego Cortes. Polycerasoidol, a Natural Prenylated Benzopyran with a Dual PPARα/PPARγ Agonist Activity and Anti-inflammatory Effect. Journal of Natural Products 2019; 82(7): 1802 doi: 10.1021/acs.jnatprod.9b00003
|